Rothmann, M. J.
Jakobsen, P. R.
Jensen, C. M.
Hermann, A. P.
Smith, A. C
Clemensen, J.
Article History
Received: 20 September 2017
Accepted: 15 February 2018
First Online: 6 March 2018
Compliance with ethical standards
:
: All authors have completed the authorship and disclosure form. CM Jensen, AC Smith, and J Clemensen have no conflict of interest. PR Jakobsen and MJ Rothmann have received a speaker fee from Eli Lilly. AP Hermann serves on advisory Boards for Eli Lilly, Amgen, and she has received research funding from Eli Lilly, in addition to a speaker fee from Eli Lilly, GSK, Genzyme, Amgen. These disclosed interests are outside the submitted work.